These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Efficacy of intravenous prourokinase and a combination of prourokinase and urokinase in acute myocardial infarction. Bode C; Schoenermark S; Schuler G; Zimmermann R; Schwarz F; Kuebler W Am J Cardiol; 1988 May; 61(13):971-4. PubMed ID: 2452564 [TBL] [Abstract][Full Text] [Related]
17. [Comparative randomized study of the effectiveness of intravenous recombinant tissue-type plasminogen activator and intravenous streptokinase in patients with acute myocardial infarct. Report of the European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator]. Verstraete M; Bory M; Collen D; Erbel R; Lennane RJ; Mathey D; Michels HR; Schartl M; Uebis R; Bernard R Klin Wochenschr; 1988; 66 Suppl 12():77-85. PubMed ID: 3126348 [TBL] [Abstract][Full Text] [Related]
18. Bolus dose response characteristics of single chain urokinase plasminogen activator and tissue plasminogen activator in a dog model of arterial thrombosis. Badylak SF; Voytik S; Klabunde RE; Henkin J; Leski M Thromb Res; 1988 Nov; 52(4):295-312. PubMed ID: 3144052 [TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of thrombolysis with alteplase (50 mg) plus tirofiban versus alteplase (100 mg) alone in acute myocardial infarction: preliminary findings. Sarullo FM; Pasquale PD; D'Alfonso G; Amerigo L; Cannizzaro S; Castello A Ital Heart J; 2001 Aug; 2(8):605-11. PubMed ID: 11577835 [TBL] [Abstract][Full Text] [Related]
20. [Intracoronary thrombolysis]. Cernigliaro C; Sansa M; Campi A; Bongo AS; Aina F; Rossi P G Ital Cardiol; 1983; 13(4):345-8. PubMed ID: 6350093 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]